Evaluation of Pulsed Field Ablation of the Posterior Nasal Nerve for Chronic Rhinitis
Part of paid clinical trials in Colorado Springs, Colorado.
- Sponsor
- Aventix Medical Inc.
- Study ID
- NCT06598319
- Status
- Recruiting
Conditions
- Chronic Rhinitis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- NOVOCLEAR™ Device — DEVICEPulsed field energy applied to soft tissues in the nasal airway, including the posterior nasal nerve distribution.
Study Details
Evaluation of safety, effectiveness and tolerability of the Aventix Medical Device used for the treatment of chronic rhinitis
Key Dates
- Start date
- Nov 15, 2024
- Status verified
- Apr 2026
- Primary completion
- Apr 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: NOVOCLEAR™ Device Treatment GroupSubjects treated with pulsed field energy applied to soft tissues in the nasal airway, including the posterior nasal nerve distribution.
Primary Outcome Measure
Mean change in Reflective Total Nasal Symptom Score (rTNSS) at 90 days compared to baseline. [ Time Frame: 90 days ]
Central Contacts
- ClinicalAdmin(510) 912-2589
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Colorado ENT and Allergy | Colorado Springs | Colorado | 80923 | Monica Davis (719) 867-7804 Bryan Davis, MD (PRINCIPAL_INVESTIGATOR) |
| Bay Area ENT | Ocean Springs | Mississippi | 39564 | Raymond Weiss, MD |
| Atkins Expert Sinus Care | San Antonio | Texas | 78256 | James Atkins, MD |
Find similar trials in Colorado Springs, CO
Related Studies
- Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic RhinitisPHASE4 · Recruiting · Endeavor Health · Evanston, Illinois